The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

AstraZeneca’s chief executive has discussed quitting Britain in a move that would deal a significant blow to the City of ...

In turn, while the overall impact from them is still yet to be seen, Mr Bailey says tightening rates further could be more ...

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...

The boss of Britain’s most valuable company, Astrazeneca, has reportedly voiced his preference to move the firm’s stock ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

London's IPO drought just hit a new lowand it's getting harder to ignore. AstraZeneca (NASDAQ:AZN), the UK's largest listed ...

Reports are circulating that AstraZeneca shares could be moving off the London exchange with its CEO favouring a US market ...

Suggestions that AstraZeneca might cross the Atlantic should act as a huge wake-up call.

AstraZeneca is reportedly considering moving its stock listing from London to the US, threatening a major hit to the FTSE 100 ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.